Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	245.34B
Revenue (ttm)	868.41B
Net Income (ttm)	15.27B
Shares Out	20.53M
EPS (ttm)	743.99
PE Ratio	16.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	700
Average Volume	6,145
Open	12,000
Previous Close	11,950
Day's Range	11,950 - 12,000
52-Week Range	10,526 - 14,100
Beta	0.54
RSI	42.72
Earnings Date	Apr 29, 2025

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 773
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2024, HOSE:DBT's revenue was 868.41 billion, an increase of 7.00% compared to the previous year's 811.62 billion. Earnings were 15.27 billion, a decrease of -5.68%.